Key Record Dates
ClinicalTrials.gov Identifier: | NCT02535078 |
---|---|
Brief Title: | Phase 1b/2 Study of the Combination of IMCgp100 With Durvalumab and/or Tremelimumab in Cutaneous Melanoma |
First Submitted : | August 26, 2015 |
First Submitted that Met QC Criteria : | August 27, 2015 |
First Posted : | August 28, 2015 (Estimate) |
Last Update Submitted that Met QC Criteria : | April 9, 2021 |
Last Update Posted : | April 14, 2021 (Estimate) |